期刊文献+

T2WI、DWI序列联合血清CA125在子宫肉瘤与非典型子宫肌瘤鉴别诊断中的应用 被引量:3

Application of T2WI,DWI sequence combined with serum CA125 in the differential diagnosis of uterine sarcoma and atypical leiomyoma
下载PDF
导出
摘要 目的探讨T2WI、扩散加权成像(diffusion weighted imaging,DWI)和平均表观扩散系数(mean apparent diffusion coefficient,mADC)联合癌抗原125(cancer antigen 125,CA125)在子宫肉瘤和非典型子宫肌瘤鉴别诊断中的应用价值。材料与方法回顾性分析2011年1月至2023年2月我院经病理证实的子宫肉瘤59例和非典型子宫肌瘤118例患者的相关资料。收集患者的T2WI、DWI序列的影像特征(包括信号强度、肿瘤最大径、mADC值)和临床相关信息(包括年龄、临床症状、绝经状态和血清CA125)。用Mann-Whitney U检验和卡方检验进行单因素分析,随后采用逻辑回归构建基于T2WI、DWI序列和血清CA125单独及联合应用的模型,采用受试者工作特征(receiver operating characteristic,ROC)曲线评估预测模型的性能,计算模型的曲线下面积(area under the curve,AUC)、敏感度和特异度。结果子宫肉瘤组患者术前血清CA125显著高于非典型子宫肌瘤组(P=0.043)。在T2WI和DWI序列上,子宫肉瘤的实性成分相较于非典型肌瘤更多表现为高信号,且mADC值显著低于非典型子宫肌瘤(P均<0.001)。术前用于鉴别二者的血清CA125的最佳截断值为23.41 U/mL,mADC的最佳截断值为1.165×10^(-3)mm^(2)/s。T2WI、DWI、mADC值和血清CA125联合应用时,AUC为0.981(95%置信区间:0.966~0.996),敏感度为98.3%,特异度为92.4%(P<0.001)。结论T2WI、DWI序列联合血清CA125可作为鉴别子宫肉瘤和非典型子宫肌瘤的有效方法。 Objective:To explore the value of T2-weighted imaging(T2WI),diffusion weighted imaging(DWI)and mean apparent diffusion coefficient(mADC)combined with cancer antigen 125(CA125)in the differential diagnosis of uterine sarcoma and atypical leiomyoma.Materials and Methods:From January 2011 to February 2023,59 patients with uterine sarcoma and 118 patients with atypical leiomyomas confirmed by pathology in our hospital were retrospectively analyzed.The imaging features of T2WI and DWI(including signal intensity of T2WI and DWI,maximum tumor diameter,mADC value)and clinical relevant information(including age,clinical symptoms,menopausal status and serum CA125)were collected.Mann-Whitney U test and chi-square test were used for univariate analysis,and then logistic regression was used to construct models based on T2WI,DWI sequence and serum CA125 alone or in combination.The receiver operating characteristic(ROC)curve was used to evaluate the performance of the prediction model,and the area under the curve(AUC),sensitivity and specificity of the model were calculated.Results:The preoperative serum CA125 levels in the uterine sarcoma group were significantly higher than those in the atypical leiomyoma group(P=0.043).On T2WI and DWI sequences,the solid component of uterine sarcoma showed more hyperintensity than that of atypical leiomyoma,and the mADC value was significantly lower than that of atypical leiomyoma(all P<0.001).The optimal preoperative cut-off value for serum CA125 used to identify the two was 23.41 U/mL,and the optimal cut-off value for mADC was 1.165×10-3 mm2/s.The combination of T2WI,DWI,mADC values and serum CA125 resulted in an AUC of 0.981,a sensitivity of 98.3%and a specificity of 92.4%(P<0.001).Conclusions:T2WI and DWI sequences combined with serum CA125 can be used as an effective method to distinguish uterine sarcoma from atypical leiomyoma.
作者 潘缘蕊 刘洋 唐明梅 刘惠 张珂 吕发金 PAN Yuanrui;LIU Yang;TANG Mingmei;LIU Hui;ZHANG Ke;LÜFajin(State Key Laboratory of Ultrasound in Medicine and Engineering,College of Biomedical Engineering,Chongqing Medical University,Chongqing 400016,China;Chongqing Key Laboratory of Biomedical Engineering,Chongqing Medical University,Chongqing 400016,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《磁共振成像》 CAS CSCD 北大核心 2023年第12期60-65,共6页 Chinese Journal of Magnetic Resonance Imaging
基金 超声医学工程国家重点实验室开放课题(编号:2022KFKT005)。
关键词 子宫肉瘤 非典型子宫肌瘤 T2加权成像 扩散加权成像 表观扩散系数 磁共振成像 癌抗原125 uterine sarcoma atypical leiomyoma T2-weighted imaging diffusion weighted imaging apparent diffusion coefficient magnetic resonance imaging cancer antigen 125
  • 相关文献

参考文献7

二级参考文献45

  • 1Prat J. FIGO staging for uterine sarcomas. International Journal of Gynecology b- Obstetrics, 2009,104(3) :179.
  • 2Tirumani SH, Ojili V, Shanbhogue AK, et al. Current concepts in the imaging of uterine sarcoma. Abdom Imaging, 2013,38(2) : 397-411.
  • 3Thomassin-Naggara I, Dechoux S, Bonneau C, et al. How to dif-ferentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol, 2013,23(8):2306-2314.
  • 4Levy A,Medjboul A, Caramella C, et al. Interest of diffusion- weighted echo-planar MR imaging and apparent diffusion coeffi- cient mapping in gynecological malignancies: A review. J Magn Reson Imaging, 2011,33(5) : 1020 1027.
  • 5Namimoto T, Yamashita Y, Awai K, et al. Combined use of T2 weighted and diffusion-weighted 3-T MR imaging for differentia- ting uterine sarcomas from benign leiomyomas. Eur Radiol, 2009, 19(11) :2756-2764.
  • 6Tamai K, Koyama T, Saga T, et al. The utility of diffusion- weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol, 2008, 18(4) : 723-730.
  • 7Poncelet C, Fauvet R, Feldmann G, et al. Prognostic value of yon Willebrand factor, CD34, CI)31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. J Surg Oncol, 2004,86(2) :84-90.
  • 8Goto A, Takeuchi S, Sugimura K, et al. Usefulness of Gd-DT- PA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosar coma from degenerated leiomyoma of the uterus, lnt J Gyneeol Cancer, 2002, 12(4) :354-361.
  • 9Kla<:ko M,Babala P,Miklos P,et al. Uterine Sarcomas - a review[J].Klin Onkol,201 2,25(5 ):340-345.
  • 10Liu Z,Ding J,Li X,etal. Endometrial stromal sarcoma arising invagina[J]. Int J Clin Exp Pathol ,2013,6( 12) : 2997-3002.

共引文献101

同被引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部